CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vizgen, Inc. the life science company dedicated to improving human health by visualizing single-cell spatial genomics information, today unveiled the MERSCOPE ® ...

Leader in spatial multi-omics technologies launches new generation of MERFISH chemistry and bridges basic and translational research with new pathology-grade, clinically relevant biomarkers CAMBRIDGE, ...

Irvine, Calif., Aug. 6, 2024 — Researchers led by the University of California, Irvine have discovered how the TREM2 R47H genetic mutation causes certain brain areas to develop abnormal protein clumps ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vizgen, Inc., the life sciences company revolutionizing spatial genomics research and driving innovation in spatial multi-omics, today announced the official launch ...

Leader in spatial multi-omics technologies launches new generation of MERFISH chemistry and bridges basic and translational research with new pathology-grade, clinically relevant biomarkers CAMBRIDGE, ...

In this presentation, Vizgen’s Instrument Product Manager will introduce you to their latest platform, the MERSCOPE® Ultra, for in situ spatial genomics powered by MERFISH technology. MERFISH ...

Vizgen, a life science company dedicated to advancing human health by visualizing single-cell spatial genomics information, has recently launched an ongoing Data Release Program, giving the scientific ...

Exploring biology in its native environment is perhaps the ideal scenario for generating better hypotheses about the cellular interactions that influence—and drive—healthy and diseased states, ...

Applying single-cell RNA sequencing has led researchers to be able to profile the entire transcriptome of cells. However, these transcriptomes prove difficult to link back to their original location ...